Economists are speculating over the future of Das in the wake of data showing the South Asian economy expanded 5.4% from July to September, a seven-quarter low and far below the Reserve Bank of India’s 7% projection.
Related Posts
Aurobindo Pharma arm CuraTeQ gets positive EMA opinion for biosimilar Zefylti
Aurobindo Pharma’s subsidiary, CuraTeQ Biologics, received a positive CHMP opinion for its filgrastim biosimilar, Zefylti, intended to treat neutropenia and mobilize peripheral progenitor cells. Zefylti […]
NSE launches mobile app and expands website to 11 regional languages
The NSE introduces its new mobile app, NSEIndia, and expands its website language support to eleven regional languages, aiding wider investor participation across India. The […]
US co Foot Locker eyes desi feet
American retailer Foot Locker is expanding into India, viewing it as a key growth market. The company has partnered with Metro Brands for store operations […]